Apr 10, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Improving drug solubility is one of the biggest challenges for pharmaceutical companies as they are always looking for new strategies to increase bioavailability of new drugs. The development of amorphous solid dispersions is one highly successful way drug...
Apr 10, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Noninvasive imaging plays a growing role in the drug development process, especially in cardiovascular. The growth in use of molecular imaging has been increasingly applied to improve and accelerate aspects of preclinical steps in drug development. These include the...
Apr 9, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Extended Release (ER) feasibility in drug delivery continues to be an important challenge for pharmaceutical and biotech drug manufacturers. There are many factors and parameters to consider including dosage form, selecting the appropriate technology process and...
Apr 8, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from solubility issues. As a result, industry has responded with the development of...
Mar 16, 2020 | All Posts, Controlled Release, Main Blog |
The Next Generation of Drug Delivery: Where Are We Headed? The drug delivery technology market continues to grow rapidly from a technology and application standpoint, particularly in the areas of oral, injectable, topical, nasal, ocular, pulmonary, implantable, and...
Recent Comments